# "Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL

> **NCT06919393** · — · RECRUITING · sponsor: **Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS** · enrollment: 60 (estimated)

## Conditions studied

- Leukemia, Lymphoblastic

## Interventions

- **OTHER:** "Triple negative" adul B-cell ALL

## Key facts

- **NCT ID:** NCT06919393
- **Lead sponsor:** Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-10-23
- **Primary completion:** 2026-01
- **Final completion:** 2026-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06919393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06919393, ""Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06919393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*